Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRECINKT: Intranasal Ketamine for Pain in Alpine Rescue
NCT02033434Phase 1Completed
- Sponsor
- University of Calgary
- Start
- Mar 2014
- Primary completion
- May 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of ketamine in pain, sponsored by University of Calgary. Primary endpoint: Analgesia at 30 months. Started Mar 2014; status: completed.
02
Drugs
ketamine
03
Conditions
pain
Beyond the preview
Go deeper on NCT02033434.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02033434.